本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

24.59
-0.4000-1.60%
盘前:24.30-0.2900-1.18%07:42 EDT
成交量:52.45万
成交额:1,299.28万
市值:27.63亿
市盈率:-14.44
高:25.00
开:24.88
低:24.51
收:24.99
52周最高:30.18
52周最低:15.96
股本:1.12亿
流通股本:9,711.04万
量比:0.61
换手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
净资产收益率:-26.91%
总资产收益率:-14.75%
市净率:4.55
市盈率(LYR):-15.34

数据加载中...

2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/23

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/06/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]